FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3208125422> ?p ?o ?g. }

• W3208125422 endingPage "e2128385" @default.
• W3208125422 startingPage "e2128385" @default.
• W3208125422 abstract "Pediatric acute myeloid leukemia (AML) requires multiple courses of intensive chemotherapy that result in neutropenia, with significant risk for infectious complications. Supportive care guidelines recommend hospitalization until neutrophil recovery. However, there are little data to support inpatient over outpatient management.To evaluate outpatient vs inpatient neutropenia management for pediatric AML.This cohort study used qualitative and quantitative methods to compare medical outcomes, patient health-related quality of life (HRQOL), and patient and family perceptions between outpatient and inpatient neutropenia management. The study included patients from 17 US pediatric hospitals with frontline chemotherapy start dates ranging from January 2011 to July 2019, although the specific date ranges differed for the individual analyses by design and relative timing. Data were analyzed from August 2019 to February 2020.Discharge to outpatient vs inpatient neutropenia management.The primary outcomes of interest were course-specific bacteremia incidence, times to next course, and patient HRQOL. Course-specific mortality was a secondary medical outcome.Primary quantitative analyses included 554 patients (272 [49.1%] girls and 282 [50.9%] boys; mean [SD] age, 8.2 [6.1] years). Bacteremia incidence was not significantly different during outpatient vs inpatient management (67 courses [23.8%] vs 265 courses [29.0%]; adjusted rate ratio, 0.73; 95% CI, 0.56 to 1.06; P = .08). Outpatient management was not associated with delays to the next course compared with inpatient management (mean [SD] 30.7 [12.2] days vs 32.8 [9.7] days; adjusted mean difference, -2.2; 95% CI, -4.1 to -0.2, P = .03). Mortality during intensification II was higher for patients who received outpatient management compared with those who received inpatient management (3 patients [5.4%] vs 1 patient [0.5%]; P = .03), but comparable with inpatient management at other courses (eg, 0 patients vs 5 patients [1.3%] during induction I; P = .59). Among 97 patients evaluated for HRQOL, outcomes did not differ between outpatient and inpatient management (mean [SD] Pediatric Quality of Life Inventory total score, 70.1 [18.9] vs 68.7 [19.4]; adjusted mean difference, -2.8; 95% CI, -11.2 to 5.6). A total of 86 respondents (20 [23.3%] in outpatient management, 66 [76.7%] in inpatient management) completed qualitative interviews. Independent of management strategy received, 74 respondents (86.0%) expressed satisfaction with their experience. Concerns for hospital-associated infections among caregivers (6 of 7 caregiver respondents [85.7%] who were dissatisfied with inpatient management) and family separation (2 of 2 patient respondents [100%] who were dissatisfied with inpatient management) drove dissatisfaction with inpatient management. Stress of caring for a neutropenic child at home (3 of 3 respondents [100%] who were dissatisfied with outpatient management) drove dissatisfaction with outpatient management.This cohort study found that outpatient neutropenia management was not associated with higher bacteremia incidence, treatment delays, or worse HRQOL compared with inpatient neutropenia management among pediatric patients with AML. While outpatient management may be safe for many patients, course-specific mortality differences suggest that outpatient management in intensification II should be approached with caution. Patient and family experiences varied, suggesting that outpatient management may be preferred by some but may not be feasible for all families. Further studies to refine and standardize safe outpatient management practices are warranted." @default.
• W3208125422 created "2021-11-08" @default.
• W3208125422 creator A5012480733 @default.
• W3208125422 creator A5012989745 @default.
• W3208125422 creator A5014330639 @default.
• W3208125422 creator A5014826208 @default.
• W3208125422 creator A5017202683 @default.
• W3208125422 creator A5020819633 @default.
• W3208125422 creator A5024573751 @default.
• W3208125422 creator A5027997230 @default.
• W3208125422 creator A5037359116 @default.
• W3208125422 creator A5044036715 @default.
• W3208125422 creator A5045933353 @default.
• W3208125422 creator A5051365423 @default.
• W3208125422 creator A5055721856 @default.
• W3208125422 creator A5056916024 @default.
• W3208125422 creator A5060672964 @default.
• W3208125422 creator A5064741369 @default.
• W3208125422 creator A5065917336 @default.
• W3208125422 creator A5066663231 @default.
• W3208125422 creator A5066681200 @default.
• W3208125422 creator A5069073123 @default.
• W3208125422 creator A5072531702 @default.
• W3208125422 creator A5079420293 @default.
• W3208125422 creator A5082146332 @default.
• W3208125422 creator A5087504195 @default.
• W3208125422 creator A5091273474 @default.
• W3208125422 date "2021-10-28" @default.
• W3208125422 modified "2023-10-16" @default.
• W3208125422 title "Medical Outcomes, Quality of Life, and Family Perceptions for Outpatient vs Inpatient Neutropenia Management After Chemotherapy for Pediatric Acute Myeloid Leukemia" @default.
• W3208125422 cites W1508847054 @default.
• W3208125422 cites W1910030854 @default.
• W3208125422 cites W1947485284 @default.
• W3208125422 cites W1975959396 @default.
• W3208125422 cites W1980100654 @default.
• W3208125422 cites W1993151769 @default.
• W3208125422 cites W2006805573 @default.
• W3208125422 cites W2018591383 @default.
• W3208125422 cites W2020552122 @default.
• W3208125422 cites W2027295937 @default.
• W3208125422 cites W2030504196 @default.
• W3208125422 cites W2068178890 @default.
• W3208125422 cites W2073287619 @default.
• W3208125422 cites W2083165546 @default.
• W3208125422 cites W2106591709 @default.
• W3208125422 cites W2118924327 @default.
• W3208125422 cites W2122301998 @default.
• W3208125422 cites W2147786645 @default.
• W3208125422 cites W2169923083 @default.
• W3208125422 cites W2746851050 @default.
• W3208125422 cites W2924950986 @default.
• W3208125422 cites W3004873674 @default.
• W3208125422 cites W4233717107 @default.
• W3208125422 cites W4240749674 @default.
• W3208125422 cites W4247275325 @default.
• W3208125422 cites W4251664624 @default.
• W3208125422 cites W4254410139 @default.
• W3208125422 cites W4256333992 @default.
• W3208125422 doi "https://doi.org/10.1001/jamanetworkopen.2021.28385" @default.
• W3208125422 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8554641" @default.
• W3208125422 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34709389" @default.
• W3208125422 hasPublicationYear "2021" @default.
• W3208125422 type Work @default.
• W3208125422 sameAs 3208125422 @default.
• W3208125422 citedByCount "5" @default.
• W3208125422 countsByYear W32081254222022 @default.
• W3208125422 countsByYear W32081254222023 @default.
• W3208125422 crossrefType "journal-article" @default.
• W3208125422 hasAuthorship W3208125422A5012480733 @default.
• W3208125422 hasAuthorship W3208125422A5012989745 @default.
• W3208125422 hasAuthorship W3208125422A5014330639 @default.
• W3208125422 hasAuthorship W3208125422A5014826208 @default.
• W3208125422 hasAuthorship W3208125422A5017202683 @default.
• W3208125422 hasAuthorship W3208125422A5020819633 @default.
• W3208125422 hasAuthorship W3208125422A5024573751 @default.
• W3208125422 hasAuthorship W3208125422A5027997230 @default.
• W3208125422 hasAuthorship W3208125422A5037359116 @default.
• W3208125422 hasAuthorship W3208125422A5044036715 @default.
• W3208125422 hasAuthorship W3208125422A5045933353 @default.
• W3208125422 hasAuthorship W3208125422A5051365423 @default.
• W3208125422 hasAuthorship W3208125422A5055721856 @default.
• W3208125422 hasAuthorship W3208125422A5056916024 @default.
• W3208125422 hasAuthorship W3208125422A5060672964 @default.
• W3208125422 hasAuthorship W3208125422A5064741369 @default.
• W3208125422 hasAuthorship W3208125422A5065917336 @default.
• W3208125422 hasAuthorship W3208125422A5066663231 @default.
• W3208125422 hasAuthorship W3208125422A5066681200 @default.
• W3208125422 hasAuthorship W3208125422A5069073123 @default.
• W3208125422 hasAuthorship W3208125422A5072531702 @default.
• W3208125422 hasAuthorship W3208125422A5079420293 @default.
• W3208125422 hasAuthorship W3208125422A5082146332 @default.
• W3208125422 hasAuthorship W3208125422A5087504195 @default.
• W3208125422 hasAuthorship W3208125422A5091273474 @default.
• W3208125422 hasBestOaLocation W32081254221 @default.
• W3208125422 hasConcept C120665830 @default.
• W3208125422 hasConcept C121332964 @default.
• W3208125422 hasConcept C126322002 @default.
• W3208125422 hasConcept C160735492 @default.

• next